Chase Investment Counsel Corp Pfizer Inc Transaction History

Chase Investment Counsel Corp

$296 Million
Q3 2024

A detailed history of Chase Investment Counsel Corp transactions in Pfizer Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 182,784 shares of PFE stock, worth $4.69 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

182,784

Holding current value

$4.69 Million

% of portfolio

1.79%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $5.06 Million - $5.74 Million	182,784 New	182,784 $5.29 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $740,059 - $865,055	23,062 Added 199.55%	34,619 $1.15 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $20,227 - $23,402	560 Added 5.09%	11,557 $423,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $36,553 - $47,587	928 Added 9.22%	10,997 $448,000
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $75,358 - $98,372	-1,805 Reduced 15.2%	10,069 $515,000
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $23,497 - $27,860	505 Added 4.44%	11,874 $622,000
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $31,338 - $38,832	685 Added 6.41%	11,369 $588,000
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $16,982 - $25,173	-411 Reduced 3.7%	10,684 $630,000
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $852,706 - $1.1 Million	-21,725 Reduced 66.19%	11,095 $477,000
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $785,351 - $889,671	21,870 Added 199.73%	32,820 $1.29 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $33,992 - $38,336	1,015 Added 10.22%	10,950 $396,000
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $31,127 - $39,580	-930 Reduced 8.56%	9,935 $365,000
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $61,722 - $72,414	-1,944 Reduced 15.18%	10,865 $398,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $91,625 - $111,154	3,042 Added 31.15%	12,809 $418,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $8,244 - $11,779	305 Added 3.22%	9,767 $318,000
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $362 - $410	-11 Reduced 0.12%	9,462 $370,000
Q3 2019 Oct 29, 2019	BUY	$32.49 - $42.13 $4,743 - $6,150	146 Added 1.57%	9,473 $340,000
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $63,675 - $69,957	1,698 Added 22.26%	9,327 $396,000
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $29,044 - $33,114	-755 Reduced 9.01%	7,629 $333,000
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $40,295 - $48,875	1,169 Added 16.2%	8,384 $369,000
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $37,927 - $40,433	1,150 Added 18.96%	7,215 $261,000
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $35,420 - $41,092	-1,110 Reduced 15.47%	6,065 $215,000
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $222,425 - $245,026	7,175	7,175 $256,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Account

Chase Investment Counsel Corp Pfizer Inc Transaction History